News for Herantis Pharma Oyj (HRPMF)

Mar 06, 2025 / 12:30PM GMTAntti Vuolanto - Herantis Pharma Oyj - Chief Executive Officer Welcome to Herantis Pharma Oyj 2024 results webinar. In this webinar, w

Aug 22, 2024 / 07:00AM GMTAntti Vuolanto - Herantis Pharma Oyj - Chief Executive Officer Good morning. My name is Antti Vuolanto, I'm the CEO of Herantis Pharma

Mar 06, 2024 / 07:30AM GMTAntti Vuolanto - Herantis Pharma Oyj - CEO Welcome to Herantis Pharma 2023 report webinar. My name is Antti Vuolanto I'm the CEO of He

Aug 24, 2023 / 07:00AM GMTOperator This meeting is being recorded.Gabriela Urquilla - Herantis Pharma plc - IR This is Gabriela Urquilla, Investor Relations for

Aug 25, 2022 / 05:00AM GMTJulie Silber - Herantis Pharma Oyj - IR This call is being recorded. And for the duration of the call, your lines will be in listen-on

Mar 03, 2022 / 08:00AM GMTJulie Silber - Herantis Pharma Oyj - IR Good morning and welcome to the Herantis Pharma second half of 2021 live webinar. My name is J

Herantis Pharma has signed European Innovation Council Accelerator grant agreement Herantis Pharma Plc, Press release, 12 April 2023 at 08:00 a.m. EEST ... | April 12, 2023

Herantis Pharma Announces Paper in Journal Genes on biomarker-driven approaches in Parkinson's Disease Herantis Pharma Plc, Press Release, 30 September 2021 at... | September 30, 2021

Herantis Pharma Plc, Press Release, 28May 2021 at 8:00 EET Herantis Pharma Plc , focusing on disease modifying therapies for debilitating neurodegenerative diseases, today announced... | May 28, 2021